★ Limited preview cohort

Help shape BIGAN before launch.

We're inviting a small group of pharmaceutical and biotech professionals to use BIGAN ahead of public release — and tell us what works, what's missing, and where it can go further.

Free access for the duration of the preview period.

Direct line to the founder — your feedback shapes the roadmap, not a ticket queue.

First access to new tools and modules as they roll out.

Founding member pricing when the paid plan launches.

What we ask in return

A short NDA, real use over a 2-week structured preview, and honest feedback — what worked, what didn't, what you wish it could do.

After the preview, you'll be the first to hear about pricing and launch plans, with founding-member benefits reserved for cohort participants.

Request preview access

Takes about 90 seconds. We'll be in touch within a week.

First name *

Last name *

Work email *

A work email helps us prioritize industry professionals.

Company or organization

Your role *

Years of GMP experience *

What would you most want to use BIGAN for?

I understand the preview requires signing a short NDA and providing feedback during a 2-week structured period.

We'll only use your information to evaluate your preview request and contact you about BIGAN. Never shared, never sold.

Request received.

Thanks for your interest in BIGAN. We'll review your request and reach out within a week with next steps. Cohort spots are limited — if it's a fit, we'll send the NDA and your access link together.

Watch your inbox for an email from info@ahme.ai.